Filter Results:
(319)
Show Results For
- All HBS Web
(319)
- People (1)
- News (59)
- Research (210)
- Events (1)
- Multimedia (1)
- Faculty Publications (99)
Show Results For
- All HBS Web
(319)
- People (1)
- News (59)
- Research (210)
- Events (1)
- Multimedia (1)
- Faculty Publications (99)
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords: Anne Kavanagh
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that... View Details
- Profile
Rocio Parra
Why was getting a business education important to you? As a consultant, I had the opportunity to work in a variety of industries from pharmaceuticals and medical devices to government and consumer packaged goods. Through these... View Details
Keywords: Retail
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
Steve Cagnetta
Steve Cagnetta is a co-founder and Principal of Company Counsel, LLC, an out-sourced general counsel firm focused on representing emerging companies. He has spent the past 20+ years advising entrepreneurs and startups on the business and... View Details
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of Novartis AG, the world’s... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on drug price growth. Today,... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs what kinds of services. These things are all connected, and changing one piece, or plugging an... View Details
- 15 Dec 2024
- News
After Ozempic
these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
A Time To Celebrate: As with every year, Class Day and Commencement were filled with many memorable moments. Among the general scenes of pomp and pageantry were (middle) the faculty recipients of the Class of 2011’s awards for excellence... View Details
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
States, Europe, and Japan, it was supposed to examine two sectors: first, the chemical and pharmaceutical industries, which helped bring about the Second Industrial Revolution between the 1880s and 1920s, and second, consumer electronics... View Details
Keywords: by Jim Aisner
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
leaders remain oblivious to an emerging threat or problem—a lack of attention that can plague even the most skilled executives. After European Commission regulators refused to approve General Electric's $42 billion acquisition of... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
Dean Nitin Nohria has announced that the Bertarelli Foundation of Switzerland, cochaired by Ernesto Bertarelli (MBA 1993), has established the Bertarelli Foundation Health & Life Sciences Entrepreneurship Fund with a generous gift to... View Details
- 01 Mar 2005
- News
Facing Ambiguity
successfully executed in a paper case.” The case, which will be taught this spring in the MBA second-year course General Management: Processes and Action, debuted last fall in a customized Executive Education program for a group of View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
general purpose (e.g., quality management) to highly market specific (e.g., knowing how to manufacture an airplane wing). To illustrate the potential of the framework to shed new light on traditional strategy questions, the article... View Details
Keywords: Sean Silverthorne
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
infertility: eggs, sperm, and wombs. Sometimes, these components are sold along with IVF treatment—when a couple purchases eggs, for example, they are subsequently used for an IVF procedure—but they are often provided by individual brokers. Then there are the View Details
- Web
Kraft Accelerator
Hear Our Mission Hear Our Mission The Generation of Cures Following the loss of Myra Kraft, the Kraft Family Foundation vowed to get better solutions for patients. Speaking with a number of cure-seeking organizations, they asked a... View Details